RSV vaccine to protect infants gets green light from FDA advisors

Faint data signal of possible increased risk of premature birth caused some concern.

https://arstechnica.com/health/2023/05/rsv-vaccine-to-protect-infants-gets-green-light-from-fda-advisors/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

Reply to this note

Please Login to reply.

Discussion

No replies yet.